statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Latest Ratings for RXRX
 DateFirmActionFromTo Mar 2022SVB LeerinkDowngradesOutperformMarket Perform Dec 2021SVB LeerinkMaintainsOutperform Sep 2021BerenbergInitiates Coverage OnBuy
 View More...

Demystifying Recursion Pharmaceuticals: Insights From 4 Analyst Reviews

Recursion reported first-quarter revenue of $13.491 million, which beat analyst estimates of $12.65 million, according to Benzinga Pro. The company reported a quarterly loss of 39 cents per share...

Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know

(RXRX) - Analyzing Recursion Pharmaceuticals's Short Interest

AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029 AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029 PR Newswire VANCOUVER, BC, April 25, 2024 USA News Group...

AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029

Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals

Recursion Pharmaceuticals Inc Director Blake Borgeson Sells 11,447 Shares

SALT LAKE CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...

Recursion to Participate in Upcoming Investor Conference

For the last three days, A.I.dvisor has detected that RXRX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Recursion Pharmaceuticals (RXRX, $9.38) Aroon Indicator entered a Downtrend on April 01, 2024.

In trading on Tuesday, shares of Recursion Pharmaceuticals Inc (RXRX) crossed below their 200 day moving average of 9.32, changing hands as low as 8.67 per share. Recursion Pharmaceuticals...

Recursion Pharmaceuticals Breaks Below 200-Day Moving Average - Notable for RXRX

Poseida Therapeutics (NASDAQ:PSTX  Get Free Report) and Recursion Pharmaceuticals (NASDAQ:RXRX  Get Free Report) are both medical companies, but which is the superior investment? We...

Recursion Pharmaceuticals (NASDAQ:RXRX) and Poseida Therapeutics (NASDAQ:PSTX) Critical Review

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.

Watchers	4,254
52-Wk Low	$4.92
52-Wk High	$16.75

Volume	6.97M
52-Wk High	$16.75
52-Wk Low	$4.92

RXRX Recursion Pharmaceuticals Inc - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals